Search results
Abbott Laboratories (NYSE:ABT) Stake Raised by Westwood Holdings Group Inc.
ETF DAILY NEWS· 24 hours agoWestwood Holdings Group Inc. grew its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 2.4% during the 4th quarter, according to its most recent 13F filing with the SEC. The ...
Is Abbott Laboratories (NYSE:ABT) the Best Value Dividend Aristocrat Stock?
Insider Monkey via Yahoo Finance· 4 days agoWe recently compiled the list of 25 Best Dividend Aristocrats Stocks According to Analysts. Since...
Insider Selling: Funck, Jr. Robert E., Abbott Laboratories [ABT] EXECUTIVE VICE PRESIDENT divested...
Knox Daily· 3 days agoInvestors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Abbott Laboratories shares valued at $1,055,819 were sold by Funck, Jr. Robert E. on May ...
California State Teachers Retirement System Buys 25,322 Shares of Abbott Laboratories (NYSE:ABT)
ETF DAILY NEWS· 7 days agoCalifornia State Teachers Retirement System raised its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 0.9% in the fourth quarter, according to the company in its most recent filing ...
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
Zacks via Yahoo Finance· 5 days agoAbbott (ABT) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good...
Abbott Laboratories loses bid to halt Glucerna class action
Reuters· 4 days agoLitigation claiming that Abbott Laboratories is marketing Glucerna shakes and nutritional powders with harmful ingredients can move forward, a California federal judge said Wednesday. , opens ...
Abbott Laboratories may have misled diabetic customers
Courthouse News Service· 4 days agoA company touting meal replacement shakes and powders as healthy for diabetics cannot dodge most...
Class Action Against Abbott's Glucerna Products Proceeds in Federal Court - Abbott Laboratories...
Benzinga· 3 days agoA California federal judge has reportedly allowed litigation to proceed against Abbott Laboratories...
Abbott share maintains Buy rating on FDA clearance By Investing.com
Investing.com· 7 days agoOn Monday, BTIG confirmed its Buy rating and $135.00 stock price target for Abbott Laboratories...
Berkshire Hathaway, Chipotle, More NYSE Stocks Hit With Trading Halts Triggered By Technical Issues...
Benzinga· 7 days agoNYSE experiences trading halts Monday due to a technical issue. Stocks like Berkshire Hathaway and...